SCHEMBL1938809

SCHEMBL1938809

O=C(NCCNC(=O)C1CCN(C(=O)O)C1)OCc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.54
SMN1; SMN2 Q16637 4/20 0.52
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
ITGB3 P05106 1/20 0.51
ITGA2B P08514 1/20 0.51
LMNA P02545 1/20 0.50
CYP2C19 P33261 1/20 0.50
TPSAB1 Q15661 1/20 0.49
TPSD1 Q9BZJ3 1/20 0.49
TPSG1 Q9NRR2 1/20 0.49
NPSR1 Q6W5P4 1/20 0.48
ALDH1A1 P00352 2/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
HPGD P15428 1/20 0.47
KEAP1 Q14145 1/20 0.47
NFE2L2 Q16236 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1938810 1.00 HTT (0.54) HTTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL27996446 0.93 HTT (0.58) HTTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL2263069 0.86 ITGB3 (0.58) HTTSMN1; SMN2NPC1RAB9AITGB3
SCHEMBL2263064 0.86 ITGB3 (0.58) HTTSMN1; SMN2NPC1RAB9AITGB3
SCHEMBL2263067 0.86 ITGB3 (0.58) HTTSMN1; SMN2NPC1RAB9AITGB3
SCHEMBL20494873 0.85 MEN1 (0.52) HTTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL12812726 0.83 KMT2A (0.64) HTTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL1938768 0.82 HTT (0.64) HTTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL25217752 0.82 TPSAB1 (0.59) HTTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL13741073 0.82 TPSAB1 (0.53) SMN1; SMN2NPC1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331523-A1 PYRIDINE AND PYRIMIDINE BASED COMPOUNDS AS WNT SIGNALING PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2011-06-15 EP disclosed
WO-2010041054-A1 PYRIDINE AND PYRIMIDINE BASED COMPOUNDS AS WNT SIGNALING PATHWAY INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2010-04-15 WO disclosed